Effect of Myofascial Release With and Without Taping in Patient With Heel Spur:
MFR-Taping
1 other identifier
interventional
38
1 country
1
Brief Summary
The current study is a randomized controlled trial comparing the effectiveness of myofascial release therapy used alone versus myofascial release combined with clinical taping for individuals with heel spurs. The trial aims to evaluate improvements in pain, foot function, and overall disability. Interventions will be delivered twice weekly for a specified duration. The primary outcome is pain reduction, while secondary outcomes include improved foot function and reduced disability. The hypothesis is that the combination of myofascial release and taping will result in significantly greater clinical improvements compared to myofascial release alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 29, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 6, 2026
CompletedFirst Submitted
Initial submission to the registry
May 9, 2026
CompletedFirst Posted
Study publicly available on registry
May 15, 2026
CompletedMay 18, 2026
May 1, 2026
23 days
May 9, 2026
May 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain Intensity
Pain intensity will be measured using the Visual Analog Scale (VAS), where participants mark their pain level on a 100mm line ranging from "no pain" (0) to "worst imaginable pain" (100). Higher scores indicate greater pain intensity.
Baseline and 4 weeks post-intervention.
Secondary Outcomes (2)
Foot Function
Baseline and 4 weeks
Disability level
Baseline and 4 weeks
Study Arms (2)
Myofascial Release with Clinical Taping
EXPERIMENTALParticipants in this arm will receive a combination of myofascial release therapy and clinical taping. Myofascial release will be applied to the plantar fascia and the posterior chain muscles. Following the manual therapy, clinical taping (such as Kinesiology tape or rigid tape, depending on your specific protocol) will be applied to the affected foot to provide mechanical support and proprioceptive feedback. Sessions will be conducted twice weekly.
Myofascial Release Alone
ACTIVE COMPARATORParticipants in this arm will receive the standardized myofascial release protocol only. The therapy will target the plantar fascia and surrounding soft tissues to reduce restrictions and pain. No clinical taping or additional manual interventions will be applied. Sessions will be conducted twice weekly to match the frequency of the experimental group
Interventions
Participants will receive a 45-minute intervention session. The integrated components consist of manual myofascial release techniques followed by the application of clinical taping to the affected foot.
Participants will receive the same 30 minutes of specialized myofascial release (MFR) manual therapy targeting the plantar fascia and calf musculature. No clinical taping will be applied. Sessions will be conducted twice weekly to ensure a consistent treatment frequency with the experimental group.
Eligibility Criteria
You may qualify if:
- Age 30-40 years
- Both males and females
- Clinically or radiographically confirmed heel spur
- Pain intensity ≥ 3 on Visual Analog Scale
- Symptom duration ≥ 4 weeks
- Able to attend treatment sessions 3 times per week
- Able to provide informed consent
You may not qualify if:
- Previous foot or heel surgery
- Current physiotherapy treatment for heel pain
- Neurological disorders (e.g., neuropathy, radiculopathy)
- Systemic inflammatory diseases (e.g., rheumatoid arthritis, gout)
- Severe musculoskeletal deformities of the foot
- Open wounds, skin infection, or allergy to tape
- Corticosteroid injection in the last 3 months
- Pregnancy
- Any medical condition preventing safe participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Green International University
Lahore, Punjab Province, Pakistan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- This study uses single masking in which the outcome assessor is blinded to group allocation. Participants will be assigned to either the Myofascial Release with taping group or the Myofascial Release only group by an independent researcher who is not involved in assessment. The assessor responsible for recording baseline and post intervention outcomes (VAS and FFI scores) will not be informed of the participants' intervention group. To maintain blinding, participants will be instructed not to disclose their group assignment during assessments.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 9, 2026
First Posted
May 15, 2026
Study Start
April 6, 2026
Primary Completion
April 29, 2026
Study Completion
May 6, 2026
Last Updated
May 18, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- It will be available after the completion of the study.
- Access Criteria
- Through the corresponding author.
Only IPD used in the results publication will be shared.